EX-99.1 14 d190883dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

On November 23, 2020, GigCapital2 announced the pending merger of a series of integrated merger transactions.

On November 23, 2020, GigCapital2, announced that it executed the UpHealth Business Combination Agreement.

Also, on November 23, 2020, GigCapital2 announced that it executed the Cloudbreak Business Combination Agreement.

UpHealth has previously or contemporaneously entered into separate merger agreements with respect to the acquisitions by UpHealth of Behavioral Health Services, Innovations Group, Thrasys, TTC Healthcare, and a share purchase agreement providing for the purchase of 90% or more of the equity interests of Glocal. All of these entities have been acquired or are probable of being acquired under US GAAP and are therefore included in the pro forma financial statements contained herein. UpHealth has consummated the mergers of Thrasys, Behavioral Health Services, TTC Healthcare, and Glocal and they are included in the UpHealth consolidated financial statements as of March 31, 2021. The unaudited statements of operations for TTC Healthcare presented through January 24, 2021, the TTC Healthcare acquisition date, and the unaudited statements of operations for Glocal presented through March 25, 2021, the Glocal acquisition date, are shown separately, as only the activity after the acquisition date are included in the UpHealth results.

The UpHealth Business Combination Agreement

Pursuant to the terms of the UpHealth Business Combination Agreement, GigCapital2 will acquire UpHealth through the statutory merger of UpHealth Merger Sub with and into UpHealth, with UpHealth surviving the merger as a wholly owned subsidiary of GigCapital2. At the effective time of the UpHealth Business Combination, each share of UpHealth common stock will be canceled and converted into the right to receive a number of shares of GigCapital2 Common Stock equal to the Exchange Ratio. The Exchange Ratio will be equal to the Aggregate Merger Consideration divided by the sum of the aggregate number of shares of UpHealth common stock issued and outstanding immediately prior to the effective time of the UpHealth Merger. The Aggregate Merger Consideration shall not exceed 99,000,000 shares of GigCapital2 Common Stock, subject to certain adjustments, less the Thrasys Incentive Amount. UpHealth has previously entered into a share purchase agreement providing for the purchase of 90% or more of the equity interests of Glocal, with the UpHealth Business Combination Agreement providing for a purchase price adjustment for every 1% less than 90% of the equity interests that is owned by UpHealth upon the Closing. UpHealth as of the date of entry into the UpHealth Business Combination Agreement owned approximately 43% of the equity interests of Glocal. On March 26, 2021, UpHealth acquired an additional 46% of the equity interests of Glocal, and as a result, now owns 89% of the equity interests of Glocal. The Aggregate Merger Consideration may be reduced by certain share thresholds if the Glocal acquisitions at the 90% threshold is not completed. On April 27, 2021, UpHealth consummated the merger of Innovations Group.

The Cloudbreak Business Combination Agreement

Pursuant to the terms of the Cloudbreak Business Combination Agreement (and any terms used in this paragraph that are not otherwise defined are as defined in the Cloudbreak Business Combination Agreement), GigCapital2 will acquire Cloudbreak through the statutory merger of Cloudbreak Merger Sub with and into Cloudbreak, with Cloudbreak surviving the merger as a wholly owned subsidiary of GigCapital2. At the effective time of the Cloudbreak Business Combination: (i) each Cloudbreak Unit (and the membership interests represented thereby) issued and outstanding immediately prior to the Closing shall be converted into the right to receive a number of shares of GigCapital2 Common Stock equal to the Common Unit Exchange Ratio; (ii) each Series A Preferred Unit (and the membership interests represented thereby) issued and outstanding immediately prior to the Closing shall be converted into the right to receive a number of shares of GigCapital2 Common Stock equal to the Preferred Unit Exchange Ratio (in addition to any

 

1


Business Combination Share Adjustment to which each Series A Preferred Unit is entitled); and (iii) each option that is outstanding and unexercised immediately prior to the Closing, whether vested or unvested, shall be assumed by GigCapital2 and converted into an option to purchase a number of shares of GigCapital2 Common Stock in an amount set forth on the Allocation Schedule, which amount shall be equal to the product of (a) the number of Cloudbreak Units subject to such option, multiplied by (b) the Common Unit Exchange Ratio. Each holder of Exchanged Options shall also be entitled to any Business Combination Share Adjustment made pursuant to the Cloudbreak Business Combination Agreement. Additionally, immediately prior to the Closing each common warrant shall convert into Common Units in accordance with their terms. The aggregate number of shares of GigCapital2 Common Stock issuable at the Closing, and upon the exercise of all Exchanged Options on a net exercise basis, shall equal 11,500,000 shares of GigCapital2 Common Stock.

Pro Forma Condensed Combined Financial Statements

The unaudited pro forma condensed combined financial statements have been prepared using the acquisition method of accounting in accordance with Accounting Standards Codification (“ASC”) Topic 805, “Business Combinations,” (“ASC 805”) with the Company treated as the legal acquirer. Under ASC 805, UpHealth was determined to be the ultimate accounting acquirer for the UpHealth mergers. The following tables set forth an unaudited pro forma condensed combined balance sheet as of March 31, 2021, and unaudited proforma condensed combined statements of operations for the three months ended March 31, 2021, and the twelve months ended December 31, 2020 (as adjusted for conforming presentation periods for Glocal, a March 31 year-end).

The unaudited pro forma condensed combined balance sheet as of March 31, 2021 gives effect to the Acquisition as if it had occurred on that date. The pro forma balance sheet data is derived from the unaudited historical financial statements of GigCapital2 and the unaudited historical financial statements of the Merger entities as of March 31, 2021. The unaudited pro forma condensed combined statements of operations for the three months ended March 31, 2021, and the twelve months ended December 31, 2020, have been prepared to illustrate the effects of the Acquisition, as if it had occurred on January 1, 2020. The pro forma condensed combined statements of operations are derived from the unaudited financial statements of GigCapital2 for the three months ended March 31, 2021, the audited financial statements (as restated) of GigCapital2 for the year ended December 31, 2020, the unaudited financial statements of each of the UpHealth and Cloudbreak merger entities for the three months ended March 31, 2021, and the audited financial statements of each of the UpHealth and Cloudbreak merger entities for the year ended December 31, 2020.

The historical financial statements have been adjusted in the unaudited pro forma condensed combined financial statements to give effect to events that are (i) directly attributable to the Acquisition, (ii) factually supportable, and (iii) with respect to the statements of operations, expected to have a continuing impact on the combined company. The unaudited pro forma condensed combined statements of operations reflect non- recurring transaction charges directly related to the Acquisition that the combined company has incurred in furtherance of consummation of the Acquisition, as well as transaction costs incurred, but not yet recorded, subsequent to March 31, 2021. Further, the tax rate used for these unaudited pro forma condensed combined financial statements is an estimated effective tax rate, which will likely vary from the actual effective rate in periods subsequent to the completion of the Acquisition.

The unaudited pro forma condensed combined financial statements have been prepared for informational purposes only and are not necessarily indicative of what the combined company’s condensed consolidated financial position or results of operations actually would have been had the Acquisition been consummated prior to March 31, 2021, nor are they necessarily indicative of future results of operations. In addition, the unaudited pro forma combined financial statements do not purport to project the future financial position or operating results of the combined company. The fair value of each of the Merger entities’ identifiable tangible and intangible assets acquired and liabilities assumed are based on preliminary estimates and are subject to adjustment as, and if, more information is obtained within twelve months of the consummation of the Mergers.

 

2


As of the date of filing of this Form 8-K to which the following unaudited pro forma condensed combined financial statements are attached, the Company has not completed the detailed valuation work necessary to finalize the required estimated fair values of the Merger entities’ assets acquired and liabilities assumed and related allocation of purchase price. The purchase price allocation and related depreciation and amortization included in the unaudited pro forma condensed combined financial statements are preliminary and have been made solely for purposes of preparing these unaudited pro forma condensed combined financial statements. Management anticipates that the values assigned to the assets acquired and liabilities assumed will be finalized during the one-year measurement period following the date of completion of the Acquisition. Differences between these preliminary estimates and the final acquisition accounting may occur and these differences could have a material impact on the unaudited pro forma condensed combined financial statements and the combined company’s future results of operations and financial position. In addition, certain reclassifications have been made to the Merger entities’ historical financial statements to conform to the presentation used in the Company’s historical financial statements. Such reclassifications had no effect on the Merger entities’ previously reported financial position or results of operations.

The unaudited pro forma condensed combined financial statements do not include any adjustments for the anticipated benefits from cost savings or synergies of GigCapital2 and the merger entities’ operating as a combined company or for liabilities resulting from integration planning, as management is in the process of making these assessments. However, liabilities ultimately may be recorded for additional costs in subsequent periods related to all merger entity companies, including severance, relocation or retention costs related to employees of the merger entities, as well as other costs associated with integrating and/or restructuring the companies. The ultimate recognition of such costs and liabilities would affect amounts in the unaudited pro forma condensed combined financial statements, and such costs and liabilities could be material.

The unaudited pro forma condensed combined financial statements should be read in conjunction with the:

 

   

accompanying notes to the unaudited pro forma condensed combined financial statements;

 

   

unaudited historical financial statements of the Company as of and for the three months ended March 31, 2021;

 

   

audited historical financial statements (as restated) of the Company as of and for the year ended December 31, 2020;

 

   

unaudited historical financial statements of the merger entities as of and for the three months ended March 31, 2021; and

 

   

audited historical consolidated financial statements of the merger entities as of and for the year ended December 31, 2020 (twelve months ended March 31, 2020 for Glocal).

 

3


UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET ADJUSTMENTS

AS OF MARCH 31, 2021

 

    UpHealth
Holdings,
Inc. and
Subsidiaries
    GigCapital2,
Inc.
    Pro Forma  
    Pro Forma     Pro Forma     Transaction
Accounting
Adjustments
    Note     Pro Forma
Combined
Company
 

ASSETS

         

Current Assets:

         

Cash and cash equivalents

  $ 6,889,859     $ 1,123,749     $ 149,605,455       5(a)(1)     $ 129,649,758  
                (94,670,217     5(a)(2)        
                28,500,000       5(a)(3)        
                (113,799,088     5(a)(4)        
                152,000,000       5(a)(5)        

Restricted cash

    576,260                     576,260  

Accounts receivable, net

    19,254,368       6,082,241               25,336,609  

Inventories, net

    3,006,022                     3,006,022  

Accounts receivable, related parties

    42,816       543               43,359  

Prepaid expenses and other current assets

    6,292,360       899,577               7,191,937  
 

 

 

   

 

 

   

 

 

     

 

 

 

Total current assets

    36,061,685       8,106,110       121,636,150         165,803,945  

Cash and marketable securities, held in Trust Account

          149,605,455       (149,605,455     5(a)(6)        

Property, plant and equipment, net

    48,874,130       1,986,707               50,860,837  

Goodwill

    457,901,032       136,712,710               594,613,742  

Trade names

    9,603,292       4,150,000               13,753,292  

Developed technology

    62,792,188       5,875,000               68,667,188  

Customer relationships, net

    9,759,375       5,875,000               15,634,375  

Finance lease right-of-use asset

          4,022,003               4,022,003  

Other assets

    887,153       1,057,123               1,944,276  
 

 

 

   

 

 

   

 

 

     

 

 

 

Total assets

  $ 625,878,855     $ 317,390,108     $ (27,969,305     $ 915,299,659  
 

 

 

   

 

 

   

 

 

     

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

         

Current Liabilities:

         

Accounts payable

  $ 6,117,977     $ 2,917,831     $ 30,872,660       5(a)(7)     $ 39,908,468  

Accounts payable, related parties

    2,039,200       146,595               2,185,795  

Revolving line of credit

    9,148,776       15,000,000               24,148,776  

Accrued liabilities

    18,967,660       4,113,182               23,080,842  

Seller notes

    85,799,088       28,000,000       (113,799,088     5(a)(11)        

Other current liabilities

    908,141             17,513,825       5(a)(18)       18,421,966  

Finance lease liability, current portion

          2,358,123               2,358,123  

Current portion of long-term debt

    17,311,498                     17,311,498  

Current portion of derivative liabilities

                38,597,749       5(a)(8)      
38,597,749
 

Current portion of related party long-term debt

    39,000       300,000               339,000  

Current portion of paycheck protection program loan

    1,545,400       2,394,419               3,939,819  

Current portion of provide relief funds

    734,604                     734,604  

Current portion of deferred revenue

    575,963       31,139               607,102  
 

 

 

   

 

 

   

 

 

     

 

 

 

Total current liabilities

    143,187,307       55,261,289       (26,814,854       171,633,742  

Warrant liability

          425,625       1,573,883       5(a)(19)       1,999,508  

Long-term debt, net of current maturities

    14,111,181                     14,111,181  

Related party long-term debt, net of current discount and current portion

    381,283       200,000               581,283  

Convertible senior note

                98,177,338       5(a)(9)      
98,177,338
 

Debt discount

                (8,000,000     5(a)(9)       (8,000,000

 

4


    UpHealth
Holdings,
Inc. and
Subsidiaries
    GigCapital2,
Inc.
    Pro Forma  
    Pro Forma     Pro Forma     Transaction
Accounting
Adjustments
    Note     Pro Forma
Combined
Company
 

Derivative liabilities, net of current portion

                23,224,913       5(a)(10)      
23,224,913
 

Paycheck protection program loan, net of current portion

          303,681               303,681  

Finance lease liability, net of current portion

          1,664,737               1,664,737  

Deferred tax liability

    5,795,431                     5,795,431  

Other long-term obligations

    166,189                     166,189  
 

 

 

   

 

 

   

 

 

     

 

 

 

Total liabilities

    163,641,391       57,855,332       88,161,280         309,658,003  
 

 

 

   

 

 

   

 

 

     

 

 

 

Common stock subject to possible redemption at $10.00 per share

          140,608,190       (140,608,190     5(a)(12)        
 

 

 

   

 

 

   

 

 

     

 

 

 

Stockholders’ Equity:

         

Common stock

    902       575       10,284       5(a)(13)       11,761  

Additional paid-in capital

    450,693,714       123,696,326       45,937,973       5(a)(14)       624,959,707  
                26,926,117       5(a)(15)    
                (10,284     5(a)(13)    
                (4,770,315     5(a)(16)    
                (17,513,825     5(a)(18)    

Accumulated deficit

    (5,136,047     (4,770,315     4,770,315       5(a)(16)       (36,008,707
                (30,872,660     5(a)(17)        

Accumulated other comprehensive loss

    (1,158,787                   (1,158,787

Noncontrolling interest

    17,837,682                     17,837,682  
 

 

 

   

 

 

   

 

 

     

 

 

 

Total stockholders’ equity

    462,237,464       118,926,586       24,477,605         605,641,656  
 

 

 

   

 

 

   

 

 

     

 

 

 

Total liabilities and stockholders’ equity

  $ 625,878,855     $ 317,390,108     $ (27,969,305     $ 915,299,659  
 

 

 

   

 

 

   

 

 

     

 

 

 

 

5


UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET ADJUSTMENTS

AS OF MARCH 31, 2021

 

     UpHealth
Holdings, Inc.
    Innovations
Group, Inc.
and
Subsidiaries
     Pro Forma  
     Historical
March 31,
2021
    Historical
March 31,
2021
     Transaction
Accounting
Adjustments
    Note      Pro Forma
Combined
Company
 
ASSETS             

Current Assets:

            

Cash and cash equivalents

   $ 4,202,490     $ 2,687,369      $        $ 6,889,859  

Restricted cash

     576,260                       576,260  

Accounts receivable, net

     19,207,713       46,655                 19,254,368  

Inventories, net

     436,335       2,569,687                 3,006,022  

Accounts receivable, related parties

     11,469       31,347                 42,816  

Prepaid expenses and other current assets

     5,623,725       668,635                 6,292,360  
  

 

 

   

 

 

    

 

 

      

 

 

 

Total current assets

     30,057,992       6,003,693                 36,061,685  
  

 

 

   

 

 

    

 

 

      

 

 

 

Property, plant and equipment, net

     40,935,456       7,938,674                 48,874,130  

Goodwill

     311,614,544              146,286,488       5(b)(1)        457,901,032  

Trade names

     7,928,292              1,675,000       5(b)(1)        9,603,292  

Developed technology

     48,092,188              14,700,000       5(b)(1)        62,792,188  

Customer relationships, net

     9,759,375                       9,759,375  

Other assets

     864,876       22,277                 887,153  
  

 

 

   

 

 

    

 

 

      

 

 

 

Total assets

   $ 449,252,723     $ 13,964,644      $ 162,661,488        $ 625,878,855  
  

 

 

   

 

 

    

 

 

      

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

            

Current Liabilities:

            

Accounts payable

   $ 5,451,224     $ 666,753      $          6,117,977  

Accounts payable, related parties

     2,039,200                       2,039,200  

Revolving line of credit and short term debt

     9,148,776                       9,148,776  

Accrued liabilities

     18,144,514       823,146                 18,967,660  

Seller notes

     55,799,088              30,000,000       5(b)(5)        85,799,088  

Other current liabilities

     908,141                       908,141  

Current portion of long-term debt

     17,195,885       115,613                 17,311,498  

Current portion of related party long-term debt

     39,000                       39,000  

Current portion of paycheck protection program loan

     1,545,400                       1,545,400  

Current portion of provider relief funds

     734,604                       734,604  

Current portion of deferred revenue

     422,958       153,005                 575,963  
  

 

 

   

 

 

    

 

 

      

 

 

 

Total current liabilities

     111,428,790       1,758,517        30,000,000          143,187,307  
  

 

 

   

 

 

    

 

 

      

 

 

 

Long-term debt, net of current maturities

     10,148,634       3,962,547                 14,111,181  

Related party long-term debt, net of current discount and current portion

     381,283                       381,283  

Deferred tax liability

     5,795,431                       5,795,431  

Other long-term obligations

     166,189                       166,189  
  

 

 

   

 

 

    

 

 

      

 

 

 

Total liabilities

     127,920,327       5,721,064        30,000,000          163,641,391  
  

 

 

   

 

 

    

 

 

      

 

 

 

Stockholders’ Equity:

            

Common stock

     766       5,080        (5,080     5(b)(2)        902  
                  136       5(b)(3)     

Additional paid-in capital

     310,315,590              140,378,260       5(b)(4)        450,693,714  
                  (136     5(b)(3)     

Accumulated deficit

     (5,136,047     7,711,692        (7,711,692     5(b)(2)        (5,136,047

Accumulated other comprehensive loss

     (1,158,787                     (1,158,787

Noncontrolling interest

     17,310,874       526,808                 17,837,682  
  

 

 

   

 

 

    

 

 

      

 

 

 

Total stockholders’ equity

     321,332,396       8,243,580        132,661,488          462,237,464  
  

 

 

   

 

 

    

 

 

      

 

 

 

Total liabilities and stockholders’ equity

   $ 449,252,723     $ 13,964,644      $ 162,661,488        $ 625,878,855  
  

 

 

   

 

 

    

 

 

      

 

 

 

 

6


UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET ADJUSTMENTS

AS OF MARCH 31, 2021

 

    GigCapital2,
Inc.
    Cloudbreak
Health, LLC
and
Subsidiaries
    Pro Forma  
    Historical
March 31,
2021
    Historical
March 31,
2021
    Transaction
Accounting
Adjustments
    Note     Pro Forma
Combined
Company
 

ASSETS

         

Current Assets:

         

Cash and cash equivalents

  $ 145,586     $ 2,887,254     $ (1,909,091     5(c)(3)     $ 1,123,749  

Accounts receivable, net

          6,082,241               6,082,241  

Accounts receivable, related parties

    543                     543  

Prepaid expenses and other current assets

    44,832       854,745               899,577  
 

 

 

   

 

 

   

 

 

     

 

 

 

Total current assets

    190,961       9,824,240       (1,909,091       8,106,110  

Cash and marketable securities, held in Trust Account

    149,605,455                     149,605,455  

Property, plant and equipment, net

          1,986,707               1,986,707  

Goodwill

                136,712,710       5(c)(1)       136,712,710  

Trade names

                4,150,000       5(c)(1)       4,150,000  

Developed technology

          4,730,144       1,144,856       5(c)(1)       5,875,000  

Customer relationships, net

                5,875,000       5(c)(1)       5,875,000  

Operating lease right-of-use asset

          4,599,491       (4,599,491     5(c)(2)        

Finance lease right-of-use asset

          4,022,003               4,022,003  

Other assets

          1,057,123               1,057,123  
 

 

 

   

 

 

   

 

 

     

 

 

 

Total assets

  $ 149,796,416     $ 26,219,708     $ 141,373,984       $ 317,390,108  
 

 

 

   

 

 

   

 

 

     

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

         

Current Liabilities:

         

Accounts payable

    327,563       2,590,268               2,917,831  

Accounts payable, related parties

    146,595                     146,595  

Revolving line of credit

          7,253,325       7,746,675       5(c)(3)       15,000,000  

Accrued liabilities

    2,988,440       1,124,742               4,113,182  

Accrued interest

          7,421,988       (7,421,988     5(c)(3)        

Seller notes

                28,000,000       5(c)(4)       28,000,000  

Operating lease liability, current portion

          1,041,754       (1,041,754     5(c)(2)        

Finance lease liability, current portion

          2,358,123               2,358,123  

Current portion of long-term debt

          13,302,545       (13,302,545     5(c)(3)        

Current portion of related party long-term debt

    300,000       10,000,000       (10,000,000     5(c)(3)       300,000  

Current portion of paycheck protection program loan

          2,394,419               2,394,419  

Current portion of deferred revenue

          31,139               31,139  
 

 

 

   

 

 

   

 

 

     

 

 

 

Total current liabilities

    3,762,598       47,518,303       3,980,388         55,261,289  

Warrant liability

    425,625                     425,625  

Related party long-term debt, net of current discount and current portion

          200,000               200,000  

Paycheck protection program loan, net of current portion

          303,681               303,681  

Cumulative preferred stock dividends

          6,931,233       (6,931,233     5(c)(3)        

Operating lease liability, net of current portion

          4,243,040       (4,243,040     5(c)(2)        

Finance lease liability, net of current portion

          1,664,737               1,664,737  
 

 

 

   

 

 

   

 

 

     

 

 

 

Total liabilities

    4,188,223       60,860,994       (7,193,885       57,855,332  
 

 

 

   

 

 

   

 

 

     

 

 

 

Common stock subject to possible redemption, 14,060,819 shares as of March 31, 2021 at a redemption value of $10.00 per share

    140,608,190                     140,608,190  
 

 

 

   

 

 

   

 

 

     

 

 

 

Stockholders’ Equity (Deficit):

         

Common stock

    575                     575  

Preferred stock

          15,000,000       (15,000,000     5(c)(5)        

Membership units

          11,641,012       (11,641,012     5(c)(5)        

Additional paid-in capital

    9,769,743                     123,696,326  
                113,926,583       5(c)(6)    

Accumulated deficit

    (4,770,315     (61,282,298     61,282,298       5(c)(5)       (4,770,315
 

 

 

   

 

 

   

 

 

     

 

 

 

Total stockholders’ equity (deficit)

    5,000,003       (34,641,286     148,567,869         118,926,586  
 

 

 

   

 

 

   

 

 

     

 

 

 

Total liabilities and stockholders’ equity (deficit)

  $ 149,796,416     $ 26,219,708     $ 141,373,984         317,390,108  
 

 

 

   

 

 

   

 

 

     

 

 

 

 

7


UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

FOR THE THREE MONTHS ENDED MARCH 31, 2021

 

    UpHealth
Holdings,
Inc. and
Subsidiaries
    GigCapital2,
Inc.
    Pro Forma  
    March 31,
2021
    March 31,
2021
    Transaction
Accounting
Adjustments
    Note     Pro Forma
Combined
Company
 

Revenues

  $ 22,655,224     $ 7,952,873     $       $ 30,608,097  

Cost of goods and services (excluding depreciation and amortization)

    10,166,181       3,379,613               13,545,794  

Operating expenses

         

Selling, general and administrative

    12,323,009       5,881,245       30,872,660       6(a)(1)       49,076,914  

Research and development

    1,569,948                     1,569,948  

Depreciation and amortization

    4,023,580       1,047,236               5,070,817  
 

 

 

   

 

 

   

 

 

     

 

 

 
    17,916,537       6,928,481       30,872,660         55,717,678  
 

 

 

   

 

 

   

 

 

     

 

 

 

Operating loss

    (5,427,494     (2,355,221     (30,872,660       (38,655,375

Other income (expense)

         

Interest expense

    1,369,989       905,093       2,500,000       6(a)(2)       8,619,563  
                3,463,528       6(a)(3)    
                380,952       6(a)(4)    

Other expense

    5,193       (790,529             (785,336

Gain on consolidation of unconsolidated entity

    (640,360                   (640,360

Other income, net, including interest income and forgiveness of debt

    (1,211,073     (286,489             (1,497,562
 

 

 

   

 

 

   

 

 

     

 

 

 
    (476,251     (171,925     6,344,481         5,696,305  
 

 

 

   

 

 

   

 

 

     

 

 

 

Loss before income tax benefit (expense)

    (4,951,243     (2,183,296     (37,217,140       (44,351,680

Income tax benefit (expense)

    504,757       (3,258             501,499  
 

 

 

   

 

 

   

 

 

     

 

 

 

Loss before net equity in earnings of affiliate

    (4,446,486     (2,186,554     (37,217,140       (43,850,181

Equity in net earnings of affiliate

    (560,662                   (560,662
 

 

 

   

 

 

   

 

 

     

 

 

 

Net loss

    (5,007,148     (2,186,554     (37,217,140       (44,410,843

Net income attributable to redeemable stockholders

          576               576  

Net loss attributable to noncontrolling interest

    (56,173                   (56,173
 

 

 

   

 

 

   

 

 

     

 

 

 

Net loss attributable to Company common stockholders

  $ (4,950,975   $ (2,187,130   $ (37,217,140     $ (44,355,246
 

 

 

   

 

 

   

 

 

     

 

 

 

Net loss per share:

         

Basic and diluted

  $ (0.55   $ (0.15       $ (0.38

Weighted average common shares outstanding:

         

Basic and diluted

    9,018,555       14,329,625           117,605,472  

Dividends declared per share

  $     $         $  

 

     3 Months
Ended
March 31, 2021
 

Weighted-average common shares outstanding, basic and diluted:

  

GigCapital2, Inc. weighted average shares outstanding (1)

     5,751,496  

Sale of additional GigCapital2, Inc. shares in conjunction with the Business Combination

     3,000,000  

GigCapital2, Inc. shares subject to redemption reclassified to equity (2)

     4,687,252  

Rights converted to shares upon business combination (3)

     890,877  

Shares issued to UpHealth Holdings, Inc. in business combination (4)

     92,725,046  

Shares issued to Cloudbreak Healthcare, LLC in business combination (5)

     10,550,801  
  

 

 

 

Weighted-average common shares outstanding, basic and diluted:

     117,605,472  
  

 

 

 

Percent of shares owned by GigCapital2, Inc.

     12

Percent of shares owned by UpHealth Holdings, Inc.

     79

Percent of shares owned by Cloudbreak Health, LLC.

     9

 

(1)

Derived from the historical financial statements for the year ended March 31, 2021.

(2)

Shares subject to redemption are net of 9,373,567 cumulative shares redeemed.

(3)

Reflects the conversion at the time of the business combination of the outstanding Rights to shares at 1/20 share per Right.

(4)

Reflects exclusion of 4,660,266 contingent shares to be issued to UpHealth Holdings, Inc. in business combination upon award and vesting of Thrasys Incentive Amount restricted stock units.

(5)

Reflects exclusion of 949,199 exchange options exercisable into shares to be issued to Cloudbreak Health, LLC in business combination upon the exchange and exercise of the options.

 

8


UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

FOR THE THREE MONTHS ENDED MARCH 31, 2021

 

    UpHealth
Holdings,
Inc.
    TTC
Healthcare,
Inc. and
Subsidiaries
    Glocal
Healthcare
Systems
Private
Limited
(India) and
Subsidiaries
    Innovations
Group, Inc.
and
Subsidiaries
    Pro Forma  
    Historical
March 31,
2021
    Historical
January 1
through
January 24,
2021
    Historical
January 1
through
March 25,
2021
    Historical
March 31,
2021
    Transaction
Accounting
Adjustments
    Note     Pro Forma
Combined
Company
 

Revenues

  $ 12,815,280     $ 559,383     $ 2,256,364     $ 7,024,197     $       $ 22,655,224  

Cost of goods and services (excluding depreciation and amortization)

    5,886,840       724,299       220,953       3,334,089               10,166,181  

Operating expenses

             

Selling, general and administrative

    7,293,738       695,764       1,257,365       3,076,142             6(b)(1)       12,323,009  

Research and development

    1,569,948                                 1,569,948  

Depreciation and amortization

    904,043       8,323       387,098       133,488       2,590,628       6(b)(2)       4,023,580  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 
    9,767,729       704,087       1,644,463       3,209,630       2,590,628         17,916,537  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 

Operating loss

    (2,839,289     (869,003     390,948       480,478       (2,590,628       (5,427,494

Other (income) expense

             

Interest expense

    711,017       31,834       572,708       54,430               1,369,989  

Other expense

                      5,193               5,193  

Gain on consolidation of unconsolidated entity

    (640,360                               (640,360

Other income, net, including interest income and forgiveness of debt

    (37,073                 (1,174,000             (1,211,073
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 
    33,584       31,834       572,708       (1,114,377             (476,251

Income (loss) before tax benefit (expense)

    (2,872,873     (900,837     (181,760     1,594,855       (2,590,628       (4,951,243

Income tax benefit (expense)

    406,082       222,255       (123,580                   504,757  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 

Income (loss) before net equity in earnings of affiliate

    (2,466,791     (678,582     (305,340     1,594,855       (2,590,628       (4,446,486

Equity in net earnings of affiliate

    (560,662                               (560,662
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 

Net income (loss)

    (3,027,453     (678,582     (305,340     1,594,855       (2,590,628       (5,007,148

Net income (loss) attributable to noncontrolling interest

    (77,839     7,040       (8,379     23,005               (56,173
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 

Net income (loss) attributable to Company common stockholders

  $ (2,949,614   $ (685,622   $ (296,961   $ 1,571,850     $ (2,590,628     $ (4,950,975
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 

Net income (loss) per share:

             

Basic and diluted

  $ (0.42   $ (0.09   $ (0.06   $ 3.31         $ (0.55

Weighted average common shares outstanding:

             

Basic and diluted

    7,089,309       8,000,000       4,645,439       475,000       1,929,246       6(b)(3)       9,018,555  

Dividends declared per share

  $     $     $     $         $  

 

9


UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

FOR THE THREE MONTHS ENDED MARCH 31, 2021

 

    GigCapital2, Inc.     Cloudbreak
Health, LLC
and Subsidiaries
    Pro Forma  
    Historical
March 31, 2021
    Historical
March 31, 2021
    Transaction
Accounting
Adjustments
    Note     Pro Forma
Combined
Company
 

Revenues

  $     $ 7,952,873     $       $ 7,952,873  

Cost of goods and services (excluding depreciation and amortization)

          3,379,613               3,379,613  

Operating expenses

         

Selling, general and administrative

    1,624,076       4,257,169             6(c)(1)       5,881,245  

Depreciation and amortization

          1,309,034       (261,798     6(c)(2)       1,047,236  
 

 

 

   

 

 

   

 

 

     

 

 

 
    1,624,076       5,566,203       (261,798       6,928,481  
 

 

 

   

 

 

   

 

 

     

 

 

 

Operating loss

    (1,624,076     (992,943     261,798         (2,355,221

Other (income) expense

         

Interest expense

          905,093               905,093  

Other (income) expense

    (686,675     (103,854             (790,529

Other income, net, including interest income and forgiveness of debt

    (4,070     (282,419             (286,489
 

 

 

   

 

 

   

 

 

     

 

 

 
    (690,745     518,820               (171,925
 

 

 

   

 

 

   

 

 

     

 

 

 

Income (loss) before income tax expense

    (933,331     (1,511,763     261,798         (2,183,296

Income tax expense

    (3,258                   (3,258
 

 

 

   

 

 

   

 

 

     

 

 

 

Net income (loss)

    (936,589     (1,511,763     261,798         (2,186,554

Net income attributable to redeemable stockholders

    576                     576  
 

 

 

   

 

 

   

 

 

     

 

 

 

Net income (loss) attributable to Company common stockholders

  $ (937,165   $ (1,511,763   $ 261,798       $ (2,187,130
 

 

 

   

 

 

   

 

 

     

 

 

 

Net loss per share:

         

Basic and diluted

  $ (0.16   $ (0.30       $ (0.15

Weighted average common shares/member units outstanding:

         

Basic and diluted

    5,695,296       5,034,700       8,634,329       6(c)(3)       14,329,625  

Dividends declared per share

  $     $         $  

 

10


UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

FOR THE YEAR ENDED DECEMBER 31, 2020

 

    UpHealth
Holdings,
Inc. and
Subsidiaries
    GigCapital2,
Inc. and
Subsidiaries
    Pro Forma  
    Pro Forma     Pro Forma     Transaction
Accounting
Adjustments
    Note     Pro Forma
Combined
Company
 

Revenues

  $ 88,427,549     $ 28,089,434     $       $ 116,516,983  

Cost of goods and services (excluding depreciation and amortization)

    34,345,764       14,342,965               48,688,729  

Operating expenses

             

Selling, general and administrative

    38,623,137       19,039,363       32,480,393       4(a)(1)       90,142,893  

Research and development

    7,459,091                     7,459,091  

Depreciation and amortization

    14,085,088       7,821,818               21,906,906  
 

 

 

   

 

 

   

 

 

     

 

 

 
    60,167,316       26,861,181       32,480,393         119,508,890  
 

 

 

   

 

 

   

 

 

     

 

 

 

Operating loss

    (6,085,531     (13,114,712     (32,480,393       (51,680,636
 

 

 

   

 

 

   

 

 

     

 

 

 

Other income (expense)

         

Interest expense

    3,831,479       6,638,524       10,000,000       4(a)(2)       35,847,926  
        13,854,113       4(a)(3)    
        1,523,810       4(a)(4)    

Other expense

    41,256       867,828               909,084  

Other income, net, including interest income

    (5,614,850     (1,444,881             (7,059,731
 

 

 

   

 

 

   

 

 

     

 

 

 
    (1,742,115     6,061,471       25,377,923         29,697,279  
 

 

 

   

 

 

   

 

 

     

 

 

 

Loss before income tax benefit (expense)

    (4,343,416     (19,176,183     (57,858,315       (81,377,914

Income tax benefit (expense)

    248,537       (271,087             (22,550
 

 

 

   

 

 

   

 

 

     

 

 

 

Net loss

    (4,094,879     (19,447,270     (57,858,315       (81,400,464

Net income attributable to redeemable stockholders

          555,866               555,866  

Net income attributable to noncontrolling interest

    264,136                     264,136  
 

 

 

   

 

 

   

 

 

     

 

 

 

Net loss attributable to Company common stockholders

  $ (4,359,015   $ (20,003,136   $ (57,858,315     $ (82,220,466
 

 

 

   

 

 

   

 

 

     

 

 

 

Net loss per share:

         

Basic and diluted

  $ (0.48   $ (1.40       $ (0.70

Weighted average common shares outstanding:

         

Basic and diluted

    9,018,555       14,329,625           117,605,472  

Dividends declared per share

  $     $         $  

 

11


UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

FOR THE YEAR ENDED DECEMBER 31, 2020

 

    UpHealth
Holdings,

Inc.
    Thrasys,
Inc.

and
Subsidiaries
(accounting
acquirer)
    Behavioral
Services,
LLC and
Subsidiaries
    Innovations
Group, Inc.
and
Subsidiaries
    TTC
Healthcare,
Inc. and
Subsidiaries
    Glocal
Healthcare
Systems
Private
Limited

(India) and
Subsidiaries
    Pro Forma  
    Historical     Historical     Historical     Historical     Historical     Historical     Transaction
Accounting
Adjustments
    Note     Pro Forma
Combined

Company
 

Revenues

  $ 5,396,067     $ 13,504,567     $ 11,842,219       $28,335,405     $ 19,366,799     $ 9,982,492     $       $ 88,427,549  

Cost of goods and services (excluding depreciation and amortization)

    1,182,831       1,686,582       8,412,742       13,226,492       9,030,391       806,726               34,345,764  

Operating expenses

                     

Selling, general and administrative

    4,944,522       3,665,990       3,219,247       12,095,392       10,926,543       3,771,443             4(b)(1)       38,623,137  

Research and development

    874,112       6,584,979                                       7,459,091  

Depreciation and amortization

    320,748       26,626       17,890       389,000       121,469       1,315,534       11,893,821       4(b)(2)       14,085,088  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 
    6,139,382       10,277,595       3,237,137       12,484,392       11,048,012       5,086,977       11,893,821         60,167,316  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 
Operating loss     (1,926,146     1,540,390       192,340       2,624,521       (711,604     4,088,789       (11,893,821       (6,085,531
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 

Other (income) expense

                 

Interest expense

    133,831       297,103             269,382       879,366       2,251,797               3,831,479  

Other expense

                      38,914       2,342                     41,256  

Other income, net, including interest income

    (3,436     (983                 (660,851     (4,949,580             (5,614,850
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 
    130,395       296,120             308,296       220,857       (2,697,783             (1,742,115
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 

Income (loss) before tax benefit (expense)

    (2,056,541     1,244,270       192,340       2,316,225       (932,461     6,786,572       (11,893,821       (4,343,416

Income tax benefit (expense)

    (50,194                       298,731                     248,537  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 
Income (loss) before net equity in earnings of affiliate     (2,106,735     1,244,270       192,340       2,316,225       (633,730     6,786,572       (11,893,821       (4,094,879
Equity in net earnings of affiliate     (79,698                                   79,698       4(b)(3)        
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 
Net income (loss)     (2,186,433     1,244,270       192,340       2,316,225       (633,730     6,786,572       (11,814,123       (4,094,879

Net income (loss) attributable to noncontrolling interest

                      77,814       (27,407     213,729               264,136  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 

Net income (loss) attributable to Company common stockholders

  $ (2,186,433   $ 1,244,270     $ 192,340       $ 2,238,411     $ (606,323   $ 6,572,843     $ (11,814,123     $ (4,359,015
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

     

 

 

 

Net income (loss) per share:

                 

Basic and diluted

  $ (0.43   $ 0.20       N/A       4.71       (0.08     13.33         $ (0.48

Weighted average common shares outstanding:

                         

Basic and diluted

    5,091,975       6,124,226             475,000       8,000,000       492,904       3,926,580       4(b)(4)       9,018,555  

Dividends declared per share

  $     $     $     $     $     $         $  

 

12


UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS

FOR THE YEAR ENDED DECEMBER 31, 2020

 

    GigCapital2,
Inc.
    Cloudbreak
Health,
LLC and
Subsidiaries
    Pro Forma  
    Historical
(As Restated)
    Historical     Transaction
Accounting
Adjustments
    Note     Pro Forma
Combined
Company
 

Revenues

  $     $ 28,089,434     $       $ 28,089,434  

Cost of goods and services (excluding depreciation and amortization)

          14,342,965               14,342,965  

Operating expenses

         

Selling, general and administrative

    3,949,600       15,089,763             4(c)(1)       19,039,363  

Research and development

                         

Depreciation and amortization

          4,041,318       3,780,500       4(c)(2)       7,821,818  
 

 

 

   

 

 

   

 

 

     

 

 

 
    3,949,600       19,131,081       3,780,500         26,861,181  
 

 

 

   

 

 

   

 

 

     

 

 

 

Operating loss

    (3,949,600     (5,384,612     (3,780,500       (13,114,712
 

 

 

   

 

 

   

 

 

     

 

 

 

Other (income) expense

         

Interest expense

          6,638,524               6,638,524  

Other (income) expense

    930,700       (62,872             867,828  

Other income, net, including interest income

    (1,022,546     (422,335             (1,444,881
 

 

 

   

 

 

   

 

 

     

 

 

 
    (91,846     6,153,317               6,061,471  
 

 

 

   

 

 

   

 

 

     

 

 

 

Loss before income tax expense

    (3,857,754     (11,537,929     (3,780,500       (19,176,183

Income tax expense

    (271,087                   (271,087
 

 

 

   

 

 

   

 

 

     

 

 

 

Net loss

    (4,128,841     (11,537,929     (3,780,500       (19,447,270

Net income attributable to redeemable stockholders

   
555,866
 
                 
555,866
 
 

 

 

   

 

 

   

 

 

     

 

 

 

Net loss attributable to Company common stockholders

  $ (4,684,707   $ (11,537,929   $ (3,780,500     $ (20,003,136
 

 

 

   

 

 

   

 

 

     

 

 

 

Net loss per share:

         

Basic and diluted

  $ (0.88   $ (2.29       $ (1.40

Weighted average common shares/member units outstanding:

         

Basic and diluted

    5,304,752       5,034,700       9,024,873       4(c)(3)       14,329,625  

Dividends declared per share

  $     $     $         $  

 

13


NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS

1. Basis of Presentation

The unaudited pro forma condensed combined financial statements are prepared in accordance with Article 11 of SEC Regulation S-X, as amended January 1, 2021. The historical financial information has been adjusted to give effect to the events that are (i) directly attributable to the Acquisition, (ii) factually supportable and (iii) with respect to the unaudited pro forma condensed combined statements of operations, expected to have a continuing impact on the operating results of the combined company. The historical financial information of GigCapital2 and UpHealth is presented in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”).

The acquisition accounting adjustments relating to the Acquisition are preliminary and subject to change, as additional information becomes available and as additional analyses are performed. There can be no assurances that the final valuations will not result in material changes to this preliminary purchase price allocation. The unaudited pro forma condensed combined financial statements do not give effect to the potential impact of any anticipated benefits from cost savings or synergies that may result from the Acquisition or to any future integration costs. The unaudited pro forma condensed combined financial statements do not purport to project the future operating results or financial position of the combined company following the Acquisition.

Certain reclassifications have been made to UpHealth’s historical financial statements to conform to the presentation required for U.S. GAAP. Such reclassifications had no effect on UpHealth’s previously reported financial position or results of operations.

Certain reclassifications have been made to Cloudbreak’s historical financial statements to conform to the presentation required for U.S. GAAP. Such reclassifications had no effect on Cloudbreak’s previously reported financial position or results of operations.

2. Calculation of Purchase Price

Pursuant to the UpHealth Acquisition Agreement, GigCapital2 will pay $1,050,730,270 to UpHealth and its shareholders by issuing 97,385,312 shares of its common stock in its equity plus certain cash and sellers notes payable at closing (net of $8,921,943 cash acquired).

Pursuant to the Cloudbreak Acquisition Agreement, GigCapital2 will pay $139,039,329 to Cloudbreak and its shareholders in its equity plus certain cash and sellers notes payable at closing (net of $2,887,254 cash acquired). The equity is comprised of 10,550,801 shares of its common stock and 1,711,613 options exercisable into 1,711,613 shares of common stock.

 

14


The calculation of the purchase price for the individual UpHealth and Cloudbreak mergers is as follows:

Note 2a. Calculation of Purchase Price—UpHealth Holdings, Inc. Merger with GigCapital2, Inc.

 

     Total Purchase Price              
     UpHealth Holdings, Inc.
(formerly GigCapital2,
Inc.)
    UpHealth
Holdings, Inc.
    GigCapital2, Inc.  
     As of
March 31,
2021
    As of
March 31,
2021
    As of
March 31,
2021
 

Purchase Price

 

Cash at close

   $     $     $  

Notes payable to Seller

   $ 113,799,088     $ 85,799,088     $ 28,000,000  

Number of GigCapital2, Inc. common shares delivered

     107,936,113       97,385,312       10,550,801  

Multiplied by market price per share of GigCapital2, Inc. common stock

   $ 9.99     $ 10.00     $ 9.93  
  

 

 

   

 

 

   

 

 

 

Total value of GigCapital2, Inc. common shares delivered

   $ 1,078,622,579     $ 973,853,125     $ 104,769,454  
  

 

 

   

 

 

   

 

 

 

Number of GigCapital2, Inc. common options to be exchanged with Cloudbreak option holders

     1,711,613             1,711,613  

Multiplied by the fair value of the common options to be exchanged with Cloudbreak option holders as of merger agreement

   $ 5.35           $ 5.35  
  

 

 

   

 

 

   

 

 

 
   $ 9,157,130           $ 9,157,130  
  

 

 

   

 

 

   

 

 

 

Total value of GigCapital2, Inc. common shares and options delivered plus cash and sellers notes

   $ 1,087,779,708     $ 1,059,652,213     $ 141,926,583  

Less, cash acquired

     (11,809,197     (8,921,943     (2,887,254
  

 

 

   

 

 

   

 

 

 

Total Consideration Paid, Net of Cash

   $ 1,189,769,599     $ 1,050,730,270     $ 139,039,329  
  

 

 

   

 

 

   

 

 

 

 

15


Note 2b. Calculation of Purchase Price—Cloudbreak Health, LLC Merger with GigCapital2, Inc.

 

            Cloudbreak
Healthcare, LLC
 
Purchase Price           As of March 31,
2021
 

Cash at close - deferred to Seller Notes until Global Merger

      $  

Note payable to Seller to repay debt

        28,000,000  
     

 

 

 

Number of GigCapital2, Inc. common shares to be delivered

     10,550,801     

Multiplied by the closing stock price of GigCapital2, Inc. common stock on June 10, 2021

   $ 9.93        104,769,454  
  

 

 

    
     

Number of GigCapital2, Inc. common options to be exchanged with Cloudbreak option holders

     1,711,613     

Multiplied by the fair value of the common options to be exchanged with Cloudbreak option holders

   $ 5.35        9,157,130  
  

 

 

    

 

 

 

Total value of GigCapital2, Inc. common shares, option shares and cash delivered

        141,926,583  

Less, cash acquired

        (2,887,254
     

 

 

 

Total Consideration Paid, Net of Cash

      $     139,039,329  
     

 

 

 

 

16


Note 2c. Calculation of Value—GigCapital2, Inc. Reverse Merger with UpHealth Merger Entities

 

           Entities  
     Totals     UpHealth
Holdings,
Inc. As of
March 31,
2021
    Innovations
Group, Inc.
and
Subsidiaries
As of
March 31,
2021
 

Purchase Price

      

Cash at close—deferred to Seller Notes until Global Merger

   $     $     $  

Note payable to Seller

   $ 85,799,088     $ 55,799,088     $ 30,000,000  

Number of GigCapital2, Inc. common shares to be delivered at a $10.00 per share valuation

     97,385,312       83,347,486       14,037,826  

Multiplied by the negotiated issue value of $10.00 per share of GigCapital2, Inc. common stock

   $ 10.00     $ 10.00     $ 10.00  

Total value of UpHealth, Inc. common shares delivered, which will be exchanged for GigCapital2, Inc. common stock.

   $ 973,853,125     $ 833,474,865     $ 140,378,260  
  

 

 

   

 

 

   

 

 

 
   $ 1,059,652,213     $ 889,273,953     $ 170,378,260  

Less, cash acquired

     (8,921,943     (6,234,574     (2,687,369
  

 

 

   

 

 

   

 

 

 

Total Consideration Paid, Net of Cash

   $ 1,050,730,270     $ 883,039,379     $ 167,690,891  
  

 

 

   

 

 

   

 

 

 

 

17


The initial seller cash to UpHealth sellers will be paid at consummation of the global merger but are recorded as notes to sellers here. They are initially reflected in the UpHealth Mergers as notes payable to sellers.

3. Preliminary Estimated Purchase Price Allocation

The following table sets forth a preliminary allocation of the purchase price to the UpHealth Merger entities’ identifiable tangible and intangible assets acquired and liabilities assumed by the Company upon the global merger, including mergers already consummated:

Note 3a. Allocation of Purchase Price—Cloudbreak Health, LLC Merger with GigCapital2, Inc.

 

Allocation of Purchase Price:

   As of March 31,
2021
 

Accounts receivable, net

   $ 6,082,241  

Inventories

     0  

Prepaid expenses and other

     854,745  

Property, plant and equipment

     6,008,710  

Identifiable intangible assets

     15,900,000  

Other assets

     1,057,123  

Goodwill

     136,712,710  
  

 

 

 

Total assets acquired

     166,615,529  
  

 

 

 

Accounts payable

     2,590,268  

Accrued expenses and other current liabilities

     1,124,743  

Deferred revenue

     31,139  

Debt

     23,830,050  
  

 

 

 

Total liabilities assumed

     27,576,200  
  

 

 

 

Net assets acquired

   $ 139,039,329  
  

 

 

 

 

18


Note 3b. Allocation of Purchase Price - UpHealth Holdings Merger with UpHealth Merger Entities

 

    Innovations
Group, Inc. and
Subsidiaries
 

Thrasys and Behavioral Health Services consummated their mergers on November 20, 2020, TTC consummated
its merger on January 25, 2021 and Glocal consummated its merger on March 25, 2021 and are included in
consolidated UpHealth Holdings, Inc.

  As of
March 31,
2021
 
Allocation of Purchase Price:      

Accounts receivable, net

  $ 78,002  

Inventories

    2,569,687  

Prepaid expenses and other

    668,635  

Identifiable intangible assets

    16,375,000  

Property, plant and equipment

    7,938,674  

Other assets

    22,277  

Goodwill

    146,286,488  
 

 

 

 

Total assets acquired

    173,938,763  
 

 

 

 

Accounts payable

    666,753  

Accrued expenses and other current liabilities

    823,146  

Debt

    4,078,160  

Deferred revenue

    153,005  

Noncontrolling interest

    526,808  
 

 

 

 

Total liabilities assumed

    6,247,872  
 

 

 

 

Net assets acquired

  $ 167,690,891  
 

 

 

 

 

19


Note 3c. Allocation of Purchase Price—UpHealth Holdings, Inc. with acquired Merger Entities TTC and Glocal

 

     TTC
As of January 25,
2021
          Glocal
Healthcare
Systems Pvt.
Ltd, (India)

As of March 25,
2021
 

Allocation of Purchase Price:

     

Allocation of Purchase Price:

  

Accounts receivable, net

   $ 1,773,230     

Accounts receivable, net

   $ 6,460,982  

Prepaid expenses and other

     186,713     

Inventories

     325,572  

Identifiable intangible assets

     1,125,000     

Identifiable intangible assets

     38,039,263  

Property, plant and equipment

     530,719     

Property, plant, equipment and work in progress

     40,725,772  

Other assets

     281,070     

Other current assets, including short term advances

     1,979,776  

Goodwill

     57,573,723     

Other noncurrent assets, including long term advances

     508,915  
  

 

 

       

Total assets acquired

     61,470,455     

Goodwill

     91,870,771  
  

 

 

       

 

 

 

Accounts payable

     624,684     

Total assets acquired

     179,911,051  
        

 

 

 

Accrued expenses and other current liabilities

     601,802     

Accounts payable

     578,719  

Debt

     12,500,168     

Accrued expenses and other current liabilities

     8,270,680  

Deferred tax liability

     473,672     

Debt

     22,212,173  

Due to related parties

     1,393,258     

Noncontrolling interest

     17,388,713  
  

 

 

       

 

 

 

Total liabilities assumed

     15,593,584     

Total liabilities assumed

     48,450,285  
  

 

 

       

 

 

 

Net assets acquired

   $ 45,876,871     

Net assets acquired

   $ 131,460,766  
  

 

 

       

 

 

 

Property, plant and equipment

Property, plant and equipment has been adjusted to its estimated fair value. The related depreciation and amortization costs are reflected as a pro forma adjustment in the unaudited pro forma condensed combined statements of operations, and as accumulated depreciation and amortization in the pro forma condensed combined balance sheets as if the business combination took place as of the balance sheet date.

Identifiable intangible assets

Preliminary identifiable intangible assets in the pro forma financial information consist of the assets shown in the table below. The amortization related to these intangible assets is reflected as a pro forma adjustment in the unaudited pro forma condensed combined statements of operations, and as accumulated amortization in the pro forma condensed combined balance sheet as if the business combination took place as of the balance sheet date. The table below indicates the estimated fair value of the intangible assets and their estimated useful lives. These assets include the identifiable intangible assets already acquired in the consummated merger by UpHealth Holdings with Thrasys, Behavioral Health Services, TTC Healthcare, and Glocal.

 

20


UpHealth Intangible Assets Acquired or to be Acquired

 

     Approximate
Fair Value
     Estimated
Useful Life
 
     (in years)  

Definite lived intangible assets—Trade Names

   $ 9,950,000        3.00-10.00  

Definite lived intangible assets—Developed Technology

     56,362,262        3.00-10.00  

Definite lived intangible assets—Customer Relationships

     17,300,000        10.00-20.00  
  

 

 

    

Total fair value of identifiable intangible assets

   $ 83,612,262     
  

 

 

    

Cloudbreak Intangible Assets

 

     Approximate
Fair Value
     Estimated
Useful Life
 
     (in years)  

Indefinite lived intangible assets —Trade Names

   $ 4,150,000     

Definite lived intangible assets—Developed Technology

     5,875,000        8.00  

Definite lived intangible asset—Customer Relationships

     5,875,000        5.00  
  

 

 

    

Total fair value of identifiable intangible assets

   $ 15,900,000     
  

 

 

    

Goodwill represents the excess of the purchase price over the fair value of the underlying net assets acquired. Goodwill in these transactions are attributable to expected future growth in telemedicine and the synergies expected to be achieved from the combined operations of GigCapital2 and UpHealth and their subsidiaries.

Goodwill and all intangible assets identified in the purchase price allocation are expected to be deductible for tax purposes.

4. Notes to Unaudited Pro Forma Condensed Combined Statement of Operations for the twelve months ended December 31, 2020

The unaudited pro forma condensed combined statement of operations for the year ended December 31, 2020 has been adjusted to reflect accrual of non-recurring transaction costs incurred after the date of these financial statements for probable acquisitions, but prior to the effective registration date in accordance with Rule 11-02(a)(6)(i)(A) and (i)(B). In compliance with Section 3330.3 of the SEC Financial Reporting Manual, Glocal’s year ended December 31, 2020 has been conformed to present comparable periods as the other merger entities by using the overlay method. Since its fiscal year ends March 31, the first calendar quarter has been used as an overlay in both the twelve months ended March 31, and the year ended December 31.

 

 

(a)

Global

 

  1.

Accrued transaction costs incurred, which are not reflected in the historical financial statements, but were incurred through the date of this registration filing, as if the Business Combination had been consummated on January 1, 2020.

 

  2.

Interest expense has been recorded on the Convertible Note at an explicit interest rate of 6.25% as a transaction adjustment on the Global statement of operations for the year ended December 31, 2020, as if the Business Combination had been consummated on January 1, 2020.

 

  3.

Accretion expense has been recorded on the Convertible Note as a transaction adjustment on the Global statement of operations for the year ended December 31, 2020, as if the Business Combination had been consummated on January 1, 2020, using the effective interest rate method and an implicit accretion rate of 35.05%.

 

21


 

  4.

Amortization of the debt issuance costs on the Convertible Note as a transaction adjustment on the Global statement of operations for the year ended December 31, 2020, as if the Business Combination had been consummated on January 1, 2020, using the effective interest rate method and an implicit amortization rate of 19.05%.

 

(b)

UpHealth

 

  1.

Accrued transaction costs incurred, which are not reflected in the historical financial statements, but were incurred through the date of this registration filing, have been recorded as transaction adjustments on the Global statement of operations for the year ended December 31, 2020, as if the Business Combination had been consummated on January 1, 2020.

 

  2.

Depreciation and amortization have been recorded as transaction adjustments on the entity level income statement for the year ended December 31, 2020, as if the Business Combination had been consummated on January 1, 2020.

 

  3.

Eliminate net equity in earnings of affiliate which is being consolidated in these financial statements.

 

  4.

Issuance of additional shares upon consummation of merger.

 

(c)

GigCapital2

 

  1.

Accrued transaction costs incurred, which are not reflected in the historical financial statements, but were incurred through the date of this registration filing, have been recorded as transaction adjustments on the Global statement of operations for the year ended December 31, 2020, as if the Business Combination had been consummated on January 1, 2020.

 

  2.

Depreciation and amortization have been recorded as transaction adjustments on the entity level statement of operations for the year ended December 31, 2020, as if the Business Combination had been consummated on January 1, 2020.

 

22


 

  3.

Issuance of shares to Cloudbreak upon consummation of the merger.

Diluted earnings per share excluded 15,906,719 shares for the year ended December 31, 2020 related to the conversion of qualified and nonqualified incentive plan equity instruments that vest and convert upon a change of control, with an exercise price per share greater than the average fair value, resulting in an anti-dilutive effect on diluted earnings per share. Diluted earnings per share also excluded 17,817,500 shares related to the exercise of SPAC public and private warrants with an exercise price greater than the average fair value, resulting in an anti-dilutive effect on diluted earnings per share. In addition, diluted earnings per share also excluded 15,323,469 shares for the year ended December 31, 2020 related to the convertible senior subordinated note which was considered anti-dilutive.

5. Notes to Unaudited Pro Forma Condensed Combined Balance Sheet as of March 31, 2021.

The unaudited pro forma condensed combined statement of operations for the three months ended March 31, 2021 has been adjusted to reflect accrual of non-recurring transaction costs incurred after the date of these financial statements for probable acquisitions, but prior to the effective registration date in accordance with Rule 11-02(a)(6)(i)(A) and (i)(B).

 

23


(a)

Global

 

  1.

Redemption of cash from Trust Account with accrued interest, in exchange for common stock. Reflects the release of $149,605,455 balance of the Trust Account as of March 31, 2021 after giving effect to the redemption of 1,852,804 shares. All amounts held in the Trust Account are to be released upon the consummation of the Business Combination to either be used to satisfy the exercise of redemption rights or for use by UpHealth Holdings, Inc.

 

  2.

Redemption of 9,373,567 shares from the Trust Account.

 

  3.

Equity proceeds from PIPE investor, net of fees. Reflects the sale under a subscription agreement with the PIPE Investor of 3,000,000 shares at $10.00 per share for a total of $30.0 million, net of offering costs of $1.5 million.

 

  4.

Repayment of seller notes deferred from UpHealth and GigCapital2 mergers.

 

  5.

Debt proceeds from convertible note. Reflects the issuance of 6.25% Convertible Notes due in 2026 to the Convertible Note Investors totaling $160 million, the derivative liability for the conversion feature, mandatory and voluntary redemption and the interest make-whole provision and to reflect the debt discount resulting from the issuance of the convertible debt ($8.0 million), which is being amortized using the effective interest rate method at an implicit rate of 19.05%. The Convertible Notes are convertible into Common Stock at a rate of 86.9565 shares per $1,000 of principal amount. The cash is net of fees which are recorded as debt discount.

 

  6.

Redemption of proceeds from Trust Account, as noted in 5(a)(1).

 

  7.

Accrued transaction costs incurred, which are not reflected in the historical financial statements, but were incurred through the date of this registration filing.

 

  8.

Derivative liability from the Convertible Debt, current portion. Accretion of the derivative has been recorded on the Global statement of operations for the three months ended March 31, 2021, as if the Business Combination had been consummated on January 1, 2020, using the effective interest rate method and an implicit amortization rate of 35.05%.

 

  9.

Convertible debt, shown net of debt issuance costs and derivative liability value. Accretion expense has been recorded on the Convertible Note as a transaction adjustment on the Global statement of operations for the three months ended March 31, 2021, as if the Business Combination had been consummated on January 1, 2020, using the effective interest rate method and an implicit accretion rate of 35.05%.

 

  10.

Derivative liability from the Convertible Debt, noncurrent portion, using an implicit amortization rate of 35.05%.

 

  11.

Repayment of seller notes deferred from UpHealth and GigCapital2 mergers, as noted in 5(a)(4).

 

  12.

Redemption of Common Stock subject to redemption as noted in 5(a)(1).

 

  13.

Reclass additional paid-in capital to Common Stock, Par Value $0.0001 per common share.

 

  14.

Reclass stock to additional paid-in capital from Common Stock subject to redemption when redemption has expired.

 

  15.

Equity proceeds from PIPE investor, net of fees as noted in 5(a)(3) and warrant as noted in 5(a)(19)

 

  16.

Eliminate GigCapital2 accumulated deficit.

 

24


  17.

Accrued transaction costs as noted in 5(a)(7).

 

  18.

To reflect the contingent liability for the purchase of up to 1,700,000 shares at $10.30225 per share, assuming a holding period of three months from the close of the Business Combinations as defined in the Forward Share Purchase Agreement entered into with Kepos Alpha Master Fund L.P. on June 3, 2021

 

  19.

Warrants issued to PIPE Investor

 

(b)

UpHealth

 

  1.

Fair value step-up per Valuation Reports.

 

  2.

Eliminate acquired target equity accounts.

 

  3.

Reclass additional paid-in capital to Common Stock, Par Value $0.0001 per common share.

 

  4.

Adjust additional paid-in capital for purchase consideration.

 

  5.

Deferral of Seller cash payments into Seller notes until Global merger.

 

(c)

GigCapital2

 

  1.

Fair value step-up per Valuation Reports.

 

  2.

Remove ASC 842, Leases, adjustments to conform with merged company emerging growth company accounting elections.

 

  3.

Old debt and cumulative preferred stock dividends payoff and new draw on revolver.

 

  4.

Deferral of Seller cash payments into Seller notes until Global merger.

 

  5.

Eliminate acquired target equity accounts.

 

  6.

Adjust additional paid-in capital for purchase consideration.

6. Notes to Unaudited Pro Forma Condensed Combined Statement of Operations for the three months ended March 31, 2021

The unaudited pro forma condensed combined statement of operations for the three months ended March 31, 2021 has been adjusted to reflect accrual of non-recurring transaction costs incurred after the date of these financial statements for probable acquisitions, but prior to the effective registration date in accordance with Rule 11-02(a)(6)(i)(A) and (i)(B).

 

(a)

Global

 

  1.

Accrued transaction costs incurred, which are not reflected in the historical financial statements, but were incurred through the date of this registration filing, as if the Business Combination had been consummated on January 1, 2020.

 

  2.

Interest expense has been recorded on the Convertible Note at an explicit interest rate of 6.25% as a transaction adjustment on the Global statement of operations for the three months ended March 31, 2021, as if the Business Combination had been consummated on January 1, 2020.

 

  3.

Accretion expense has been recorded on the Convertible Note as a transaction adjustment on the Global statement of operations for the three months ended March 31, 2021, as if the Business Combination had been consummated on January 1, 2020, using the effective interest rate method and an implicit accretion rate of 35.05%.

 

  4.

Amortization of the debt issuance costs on the Convertible Note as a transaction adjustment on the Global statement of operations for the three months ended March 31, 2021, as if the Business Combination had been consummated on January 1, 2020, using the effective interest rate method and an implicit amortization rate of 19.05%.

 

25


(b)

UpHealth

 

  1.

Accrued transaction costs incurred, which are not reflected in the historical financial statements, but were incurred through the date of this registration filing, have been recorded as transaction adjustments on the Global statement of operations for the three months ended March 31, 2021, as if the Business Combination had been consummated on January 1, 2020.

 

  2.

Depreciation and amortization have been recorded as transaction adjustments on the entity level statement of operations for the three months ended March 31, 2021, as if the Business Combination had been consummated on January 1, 2020.

 

  3.

Issuance of additional shares upon consummation of merger.

 

(c)

GigCapital2

 

  1.

Accrued transaction costs incurred, which are not reflected in the historical financial statements, but were incurred through the date of this registration filing, have been recorded as transaction adjustments on the Global statement of operations for the three months ended March 31, 2021, as if the Business Combination had been consummated on January 1, 2020.

 

  2.

Depreciation and amortization have been recorded as transaction adjustments on the entity level statement of operations for the three months ended March 31, 2021, as if the Business Combination had been consummated on January 1, 2020.

 

  3.

Issuance of shares to Cloudbreak upon consummation of the merger.

Diluted earnings per share excluded 18,132,426 shares for the three months ended March 31, 2021 related to the conversion of qualified and nonqualified incentive plan equity instruments that vest and convert upon a change of control, with an exercise price per share greater than the average fair value, resulting in an anti-dilutive effect on diluted earnings per share. Diluted earnings per share also excluded 17,817,500 shares related to the exercise of SPAC public and private warrants with an exercise price greater than the average fair value, resulting in an anti-dilutive effect on diluted earnings per share. In addition, diluted earnings per share also excluded 15,323,469 shares for the three months ended March 31, 2021 related to the convertible senior subordinated note which was considered anti-dilutive.

 

26


PRO FORMA CONDENSED STATEMENT OF STOCKHOLDERS’ EQUITY

(unaudited)

As of March 31, 2021

 

    GigCapital2, Inc.     Cloudbreak LLC—
Preferred Stock
    Cloudbreak LLC—
Membership Units
    UpHealth Holdings, Inc.
Common Shares
    Pro Forma  
    Shares     Common
Stock
    APIC     Units     Preferred
Stock
    Units     Amount     Members
Equity
    Shares     Common
Stock
    APIC     Shares     Common
Stock
    APIC  

Beginning Balance

    5,751,496     $ 575     $ 9,769,743       3,000,000     $ 15,000,000       5,034,700     $ 11,641,012     $ –         9,018,555     $ 902     $ 450,693,714       5,751,496     $ 575     $ 9,769,743  

Surrender of Cloudbreak Preferred

          (3,000,000     (15,000,000                  

Surrender of Cloudbreak Member Units

              (5,034,700     (11,641,012              

Remaining consideration for purchase

                          10,550,801       1,055       113,926,583  

Contingent liability for forward share purchase agreement

                              (17,513,825

Surrender of UpHealth Shares

                    (9,018,555     (902     (450,693,714     92,725,046       9,273       450,693,714  

Sale of additional GigCapital 2 shares

                          3,000,000       300       26,925,817  

Public rights converted to common shares

                          890,877       89       (89

Redemption of shares in conjunction with the GigCapital2, Inc. public shares, net of redemption

                          4,687,252       469       41,157,764  
                       

 

 

   

 

 

   

 

 

 

Ending balance

                          117,605,472     $ 11,761     $ 624,959,707  
                       

 

 

   

 

 

   

 

 

 

 

27